VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42323596 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010836.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q42323596‏
024 ‎‡a 0000-0002-3470-8299‏ ‎‡2 orcid‏
024 ‎‡a 35612254100‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q42323596‏
100 0 ‎‡a Maria J. Matos‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Maria J. Matos‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Maria J. Matos‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases‏
670 ‎‡a Author's 3-Phenyl-coumarin‏
670 ‎‡a Author's 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease‏
670 ‎‡a Author's 6-Methyl-2-oxo-N-‏
670 ‎‡a Author's 6-Methyl-2-oxo-N-(quinolin-6-yl)-2H-chromene-3-carboxamide: crystal structure and Hirshfeld surface analysis‏
670 ‎‡a Author's 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.‏
670 ‎‡a Author's A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors‏
670 ‎‡a Author's A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging.‏
670 ‎‡a Author's Artificial Intelligence Applied to Flavonoid Data in Food Matrices‏
670 ‎‡a Author's Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties‏
670 ‎‡a Author's Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists‏
670 ‎‡a Author's Chromone: a valid scaffold in medicinal chemistry‏
670 ‎‡a Author's Comparative study of the 3-phenylcoumarin scaffold: Synthesis, X-ray structural analysis and semiempirical calculations of a selected series of compounds‏
670 ‎‡a Author's Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents‏
670 ‎‡a Author's Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?‏
670 ‎‡a Author's Coumarins and adenosine receptors: New perceptions in structure-affinity relationships‏
670 ‎‡a Author's Crystal structures of three 6-substituted coumarin-3-carboxamide derivatives‏
670 ‎‡a Author's Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis‏
670 ‎‡a Author's Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold.‏
670 ‎‡a Author's Efficient and irreversible antibody–cysteine bioconjugation using carbonylacrylic reagents‏
670 ‎‡a Author's Evaluation of Antioxidant and Antitrypanosomal Properties of a Selected Series of Synthetic 3-Carboxamidocoumarins‏
670 ‎‡a Author's Heterocyclic Antioxidants in Nature: Coumarins‏
670 ‎‡a Author's Improved Synthesis of 3-‏
670 ‎‡a Author's Improved Synthesis of 3-(Aminoaryl)coumarins‏
670 ‎‡a Author's In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-γ-pyrone skeleton‏
670 ‎‡a Author's In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science.‏
670 ‎‡a Author's Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.‏
670 ‎‡a Author's Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance‏
670 ‎‡a Author's MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins‏
670 ‎‡a Author's MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, study, and docking calculations‏
670 ‎‡a Author's New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors‏
670 ‎‡a Author's New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies‏
670 ‎‡a Author's Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.‏
670 ‎‡a Author's Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study‏
670 ‎‡a Author's Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry‏
670 ‎‡a Author's PEGylated PLGA nanoparticles as a smart carrier to increase the cellular uptake of a coumarin-based monoamine oxidase B inhibitor‏
670 ‎‡a Author's Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).‏
670 ‎‡a Author's QSAR and Complex Network Recognition of miRNAs in Stem Cells‏
670 ‎‡a Author's Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins‏
670 ‎‡a Author's Structural elucidation of a series of 6-methyl-3-carboxamidocoumarins.‏
670 ‎‡a Author's Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists‏
670 ‎‡a Author's Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins‏
670 ‎‡a Author's Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates‏
670 ‎‡a Author's Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors‏
670 ‎‡a Author's Synthesis and pharmacological activities of non-flavonoid chromones: a patent review (from 2005 to 2015).‏
670 ‎‡a Author's Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors‏
670 ‎‡a Author's Synthesis of 3-arylcoumarins via Suzuki-cross-coupling reactions of 3-chlorocoumarin‏
670 ‎‡a Author's Synthesis of coumarin–chalcone hybrids and evaluation of their antioxidant and trypanocidal properties‏
670 ‎‡a Author's Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases‏
670 ‎‡a Author's Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives‏
909 ‎‡a (orcid) 0000000234708299‏ ‎‡9 1‏
909 ‎‡a (scopus) 35612254100‏ ‎‡9 1‏
919 ‎‡a 3amidocoumarinsaspotentialmultifunctionalagentsagainstneurodegenerativediseases‏ ‎‡A 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases‏ ‎‡9 1‏
919 ‎‡a 3phenylcoumarin‏ ‎‡A 3-Phenyl-coumarin‏ ‎‡9 1‏
919 ‎‡a 3substitutedcoumarinsasdualinhibitorsofacheandmaoforthetreatmentofalzheimersdisease‏ ‎‡A 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a 6methyl2oxon‏ ‎‡A 6-Methyl-2-oxo-N-‏ ‎‡9 1‏
919 ‎‡a 6methyl2oxonquinolin6yl2hchromene3carboxamidecrystalstructureandhirshfeldsurfaceanalysis‏ ‎‡A 6-Methyl-2-oxo-N-(quinolin-6-yl)-2H-chromene-3-carboxamide: crystal structure and Hirshfeld surface analysis‏ ‎‡9 1‏
919 ‎‡a 8substituted3arylcoumarinsaspotentandselectivemaobinhibitorssynthesispharmacologicalevaluationanddockingstudies‏ ‎‡A 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.‏ ‎‡9 1‏
919 ‎‡a newseriesof3phenylcoumarinsaspotentandselectivemaobinhibitors‏ ‎‡A A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors‏ ‎‡9 1‏
919 ‎‡a thioetherdirectedpalladiumcleavablelinkerfortargetedbioorthogonaldrugdecaging‏ ‎‡A A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging.‏ ‎‡9 1‏
919 ‎‡a artificialintelligenceappliedtoflavonoiddatainfoodmatrices‏ ‎‡A Artificial Intelligence Applied to Flavonoid Data in Food Matrices‏ ‎‡9 1‏
919 ‎‡a bioactivecoumarinsfrommarinesourcesoriginstructuralfeaturesandpharmacologicalproperties‏ ‎‡A Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties‏ ‎‡9 1‏
919 ‎‡a chalconebasedderivativesasnewscaffoldsforha3adenosinereceptorantagonists‏ ‎‡A Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists‏ ‎‡9 1‏
919 ‎‡a chromoneavalidscaffoldinmedicinalchemistry‏ ‎‡A Chromone: a valid scaffold in medicinal chemistry‏ ‎‡9 1‏
919 ‎‡a comparativestudyofthe3phenylcoumarinscaffoldsynthesis10raystructuralanalysisandsemiempiricalcalculationsofaselectedseriesofcompounds‏ ‎‡A Comparative study of the 3-phenylcoumarin scaffold: Synthesis, X-ray structural analysis and semiempirical calculations of a selected series of compounds‏ ‎‡9 1‏
919 ‎‡a coumarinrasagilinehybridsaspotentandselectivehmaobinhibitorsantioxidantsandneuroprotectiveagents‏ ‎‡A Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents‏ ‎‡9 1‏
919 ‎‡a coumarinversuschromonemonoamineoxidasebinhibitorsquovadis‏ ‎‡A Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?‏ ‎‡9 1‏
919 ‎‡a coumarinsandadenosinereceptorsnewperceptionsinstructureaffinityrelationships‏ ‎‡A Coumarins and adenosine receptors: New perceptions in structure-affinity relationships‏ ‎‡9 1‏
919 ‎‡a crystalstructuresof36substitutedcoumarin3carboxamidederivatives‏ ‎‡A Crystal structures of three 6-substituted coumarin-3-carboxamide derivatives‏ ‎‡9 1‏
919 ‎‡a designsynthesisandantibacterialstudyofnewpotentandselectivecoumarinchalconederivativesforthetreatmentoftenacibaculosis‏ ‎‡A Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis‏ ‎‡9 1‏
919 ‎‡a developmentofnoveladenosinereceptorligandsbasedonthe3amidocoumarinscaffold‏ ‎‡A Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold.‏ ‎‡9 1‏
919 ‎‡a efficientandirreversibleantibodycysteinebioconjugationusingcarbonylacrylicreagents‏ ‎‡A Efficient and irreversible antibody–cysteine bioconjugation using carbonylacrylic reagents‏ ‎‡9 1‏
919 ‎‡a evaluationofantioxidantandantitrypanosomalpropertiesofaselectedseriesofsynthetic3carboxamidocoumarins‏ ‎‡A Evaluation of Antioxidant and Antitrypanosomal Properties of a Selected Series of Synthetic 3-Carboxamidocoumarins‏ ‎‡9 1‏
919 ‎‡a heterocyclicantioxidantsinnaturecoumarins‏ ‎‡A Heterocyclic Antioxidants in Nature: Coumarins‏ ‎‡9 1‏
919 ‎‡a improvedsynthesisof3‏ ‎‡A Improved Synthesis of 3-‏ ‎‡9 1‏
919 ‎‡a improvedsynthesisof3aminoarylcoumarins‏ ‎‡A Improved Synthesis of 3-(Aminoaryl)coumarins‏ ‎‡9 1‏
919 ‎‡a insearchfornewchemicalentitiesasadenosinereceptorligandsdevelopmentofagentsbasedonbenzoγpyroneskeleton‏ ‎‡A In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-γ-pyrone skeleton‏ ‎‡9 1‏
919 ‎‡a insilicogenotoxicityofcoumarinsapplicationofthephenolexplorerfooddatabasetofunctionalfoodscience‏ ‎‡A In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science.‏ ‎‡9 1‏
919 ‎‡a insightintotheinteractionsbetweennovelcoumarinderivativesandhumana3adenosinereceptors‏ ‎‡A Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.‏ ‎‡9 1‏
919 ‎‡a lipodystrophydefinedbyfatmassratioinhivinfectedpatientsisassociatedwithahighprevalenceofglucosedisturbancesandinsulinresistance‏ ‎‡A Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance‏ ‎‡9 1‏
919 ‎‡a maoinhibitoryactivitymodulation3phenylcoumarinsversus3benzoylcoumarins‏ ‎‡A MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins‏ ‎‡9 1‏
919 ‎‡a maoinhibitoryactivityofbromo2phenylbenzofuranssynthesisstudyanddockingcalculations‏ ‎‡A MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, study, and docking calculations‏ ‎‡9 1‏
919 ‎‡a newhalogenated3phenylcoumarinsaspotentandselectivemaobinhibitors‏ ‎‡A New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors‏ ‎‡9 1‏
919 ‎‡a newinsightsintohighlypotenttyrosinaseinhibitorsbasedon3heteroarylcoumarinsantimelanogenesisandantioxidantactivitiesandcomputationalmolecularmodelingstudies‏ ‎‡A New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies‏ ‎‡9 1‏
919 ‎‡a novel2pheynlbenzofuranderivativesasselectivebutyrylcholinesteraseinhibitorsforalzheimersdisease‏ ‎‡A Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.‏ ‎‡9 1‏
919 ‎‡a novelcoumarin3ylcarbamatesasselectivemaobinhibitorssynthesisinvitroandinvivoassaystheoreticalevaluationofadmepropertiesanddockingstudy‏ ‎‡A Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study‏ ‎‡9 1‏
919 ‎‡a oxidativestressandneurodegenerativediseaseslookingforatherapeuticsolutioninspiredonbenzopyranchemistry‏ ‎‡A Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry‏ ‎‡9 1‏
919 ‎‡a pegylatedplgananoparticlesasasmartcarriertoincreasethecellularuptakeofacoumarinbasedmonoamineoxidasebinhibitor‏ ‎‡A PEGylated PLGA nanoparticles as a smart carrier to increase the cellular uptake of a coumarin-based monoamine oxidase B inhibitor‏ ‎‡9 1‏
919 ‎‡a potentialpharmacologicalusesofchalconesapatentreviewfromjune2011‏ ‎‡A Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).‏ ‎‡9 1‏
919 ‎‡a qsarandcomplexnetworkrecognitionofmirnasinstemcells‏ ‎‡A QSAR and Complex Network Recognition of miRNAs in Stem Cells‏ ‎‡9 1‏
919 ‎‡a remarkableantioxidantpropertiesofaseriesofhydroxy3arylcoumarins‏ ‎‡A Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins‏ ‎‡9 1‏
919 ‎‡a structuralelucidationofaseriesof6methyl3carboxamidocoumarins‏ ‎‡A Structural elucidation of a series of 6-methyl-3-carboxamidocoumarins.‏ ‎‡9 1‏
919 ‎‡a structurebasedoptimizationofcoumarinha3adenosinereceptorantagonists‏ ‎‡A Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists‏ ‎‡9 1‏
919 ‎‡a synthesisandadenosinereceptorsbindingaffinitiesofaseriesof3arylcoumarins‏ ‎‡A Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins‏ ‎‡9 1‏
919 ‎‡a synthesisandbiologicalevaluationofhomogeneousthiollinkednhcaualbuminandtrastuzumabbioconjugates‏ ‎‡A Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationof6methyl3phenylcoumarinsaspotentandselectivemaobinhibitors‏ ‎‡A Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors‏ ‎‡9 1‏
919 ‎‡a synthesisandpharmacologicalactivitiesofnonflavonoidchromonesapatentreviewfrom2005to‏ ‎‡A Synthesis and pharmacological activities of non-flavonoid chromones: a patent review (from 2005 to 2015).‏ ‎‡9 1‏
919 ‎‡a synthesisandstudyofaseriesof3arylcoumarinsaspotentandselectivemonoamineoxidasebinhibitors‏ ‎‡A Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors‏ ‎‡9 1‏
919 ‎‡a synthesisof3arylcoumarinsviasuzukicrosscouplingreactionsof3chlorocoumarin‏ ‎‡A Synthesis of 3-arylcoumarins via Suzuki-cross-coupling reactions of 3-chlorocoumarin‏ ‎‡9 1‏
919 ‎‡a synthesisofcoumarinchalconehybridsandevaluationoftheirantioxidantandtrypanocidalproperties‏ ‎‡A Synthesis of coumarin–chalcone hybrids and evaluation of their antioxidant and trypanocidal properties‏ ‎‡9 1‏
919 ‎‡a synthesispharmacologicalstudyanddockingcalculationsofnewbenzocoumarinderivativesasdualinhibitorsofenzymaticsystemsinvolvedinneurodegenerativediseases‏ ‎‡A Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases‏ ‎‡9 1‏
919 ‎‡a targetingadenosinereceptorswithcoumarinssynthesisandbindingactivitiesofamideandcarbamatederivatives‏ ‎‡A Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2014‏ ‎‡9 2‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 LC|no2013117105‏
996 ‎‡2 PTBNP|1624151‏
996 ‎‡2 ISNI|0000000066472108‏
996 ‎‡2 LC|n 86061642‏
996 ‎‡2 LC|n 2019252112‏
996 ‎‡2 BNF|16635788‏
996 ‎‡2 PTBNP|431600‏
996 ‎‡2 ISNI|0000000035504285‏
996 ‎‡2 NTA|30410437X‏
996 ‎‡2 PTBNP|1349832‏
996 ‎‡2 PTBNP|237255‏
996 ‎‡2 PTBNP|1452454‏
996 ‎‡2 ISNI|0000000117502523‏
996 ‎‡2 PTBNP|166474‏
996 ‎‡2 SUDOC|111906121‏
996 ‎‡2 DNB|140552286‏
996 ‎‡2 DNB|1053291000‏
996 ‎‡2 DNB|1056585889‏
996 ‎‡2 ISNI|0000000066445935‏
996 ‎‡2 PTBNP|202889‏
996 ‎‡2 PTBNP|88544‏
996 ‎‡2 PTBNP|1875326‏
996 ‎‡2 PTBNP|1392476‏
996 ‎‡2 ISNI|0000000069808906‏
996 ‎‡2 LC|n 95921613‏
996 ‎‡2 PTBNP|1700946‏
996 ‎‡2 BLBNB|001451453‏
996 ‎‡2 NUKAT|n 2017022828‏
996 ‎‡2 PTBNP|1430769‏
996 ‎‡2 PTBNP|29645‏
996 ‎‡2 BIBSYS|7055264‏
996 ‎‡2 SUDOC|167651900‏
996 ‎‡2 PTBNP|143295‏
996 ‎‡2 LC|no2010166544‏
996 ‎‡2 BNF|12357571‏
996 ‎‡2 BLBNB|000422843‏
996 ‎‡2 PTBNP|1724222‏
996 ‎‡2 SUDOC|255630352‏
996 ‎‡2 PTBNP|1292033‏
996 ‎‡2 ISNI|0000000069688887‏
996 ‎‡2 ISNI|0000000069198220‏
996 ‎‡2 PTBNP|239907‏
996 ‎‡2 LC|n 00089032‏
996 ‎‡2 ISNI|0000000069520881‏
996 ‎‡2 ISNI|0000000069892634‏
996 ‎‡2 ISNI|0000000069120597‏
996 ‎‡2 SUDOC|149955391‏
996 ‎‡2 PTBNP|1057998‏
996 ‎‡2 ISNI|0000000070329275‏
996 ‎‡2 PTBNP|1015838‏
996 ‎‡2 PTBNP|896119‏
996 ‎‡2 PTBNP|919731‏
996 ‎‡2 DNB|1278277609‏
996 ‎‡2 SUDOC|089489764‏
996 ‎‡2 PTBNP|1880353‏
996 ‎‡2 DNB|1159252653‏
996 ‎‡2 LC|nr2002026065‏
996 ‎‡2 LC|n 2018250467‏
996 ‎‡2 PTBNP|1804297‏
996 ‎‡2 BNF|18055949‏
996 ‎‡2 PTBNP|1306660‏
996 ‎‡2 ISNI|0000000068272978‏
996 ‎‡2 ISNI|0000000041063172‏
996 ‎‡2 SUDOC|176937293‏
996 ‎‡2 PTBNP|1502048‏
996 ‎‡2 ISNI|000000007784195X‏
996 ‎‡2 ISNI|0000000069020430‏
996 ‎‡2 NII|DA19625296‏
996 ‎‡2 DNB|120202257X‏
996 ‎‡2 PTBNP|1596443‏
996 ‎‡2 DNB|1026946344‏
996 ‎‡2 SUDOC|129011363‏
996 ‎‡2 BNF|15108435‏
996 ‎‡2 PTBNP|1417603‏
996 ‎‡2 PTBNP|1053749‏
996 ‎‡2 PTBNP|967279‏
996 ‎‡2 LC|n 94074864‏
996 ‎‡2 LC|n 2022253952‏
996 ‎‡2 DNB|1074668952‏
996 ‎‡2 CAOONL|ncf10709177‏
996 ‎‡2 ISNI|000000004003840X‏
996 ‎‡2 BIBSYS|5073418‏
996 ‎‡2 ISNI|0000000052413596‏
996 ‎‡2 PTBNP|133114‏
996 ‎‡2 ISNI|0000000070029272‏
996 ‎‡2 PTBNP|910641‏
996 ‎‡2 ISNI|0000000070335739‏
996 ‎‡2 ERRR|a11483465‏
996 ‎‡2 PTBNP|1243273‏
996 ‎‡2 LC|n 79020939‏
996 ‎‡2 LC|n 2006211651‏
996 ‎‡2 ISNI|0000000069113055‏
996 ‎‡2 DNB|1057715166‏
996 ‎‡2 ISNI|0000000069008271‏
996 ‎‡2 SUDOC|14995574X‏
996 ‎‡2 PTBNP|1562047‏
996 ‎‡2 DNB|1057613762‏
996 ‎‡2 ISNI|0000000068823936‏
996 ‎‡2 PTBNP|260669‏
996 ‎‡2 DNB|138062668‏
996 ‎‡2 BNF|12135352‏
996 ‎‡2 SUDOC|076511987‏
996 ‎‡2 ISNI|0000000069904252‏
996 ‎‡2 ISNI|0000000069119588‏
996 ‎‡2 LC|no2009141718‏
996 ‎‡2 ISNI|0000000068714588‏
996 ‎‡2 PTBNP|1726486‏
996 ‎‡2 CAOONL|ncf10723822‏
996 ‎‡2 PLWABN|9812830927705606‏
996 ‎‡2 ISNI|0000000079019249‏
996 ‎‡2 PTBNP|280749‏
996 ‎‡2 LC|n 86830349‏
996 ‎‡2 SUDOC|248233424‏
996 ‎‡2 LC|n 2018044676‏
996 ‎‡2 LC|n 95093206‏
996 ‎‡2 ISNI|0000000069993945‏
996 ‎‡2 PTBNP|99958‏
996 ‎‡2 ISNI|0000000070406103‏
996 ‎‡2 PTBNP|1191448‏
996 ‎‡2 LC|n 2019028474‏
996 ‎‡2 PTBNP|1446253‏
996 ‎‡2 DNB|1056764538‏
996 ‎‡2 LC|n 95025921‏
996 ‎‡2 PTBNP|64297‏
996 ‎‡2 SUDOC|256728623‏
996 ‎‡2 BLBNB|000341769‏
996 ‎‡2 BLBNB|001427069‏
996 ‎‡2 ISNI|0000000097156810‏
996 ‎‡2 PTBNP|1565481‏
996 ‎‡2 NUKAT|n 2005106682‏
996 ‎‡2 ISNI|0000000070741227‏
996 ‎‡2 ISNI|0000000069912738‏
996 ‎‡2 PTBNP|35268‏
996 ‎‡2 PTBNP|1629400‏
996 ‎‡2 NII|DA12926206‏
996 ‎‡2 PTBNP|152344‏
996 ‎‡2 ISNI|0000000068590810‏
996 ‎‡2 PTBNP|1396534‏
996 ‎‡2 BLBNB|001016053‏
996 ‎‡2 SUDOC|253745233‏
996 ‎‡2 DNB|1157376266‏
996 ‎‡2 LC|no 94007741‏
996 ‎‡2 LC|no2010092018‏
996 ‎‡2 NYNYRILM|300483‏
996 ‎‡2 BLBNB|001477637‏
996 ‎‡2 BLBNB|001477739‏
996 ‎‡2 LC|no2012028267‏
996 ‎‡2 ISNI|0000000070091842‏
996 ‎‡2 LC|no2019109556‏
996 ‎‡2 ISNI|0000000070103073‏
996 ‎‡2 PTBNP|1712837‏
996 ‎‡2 BLBNB|000188064‏
996 ‎‡2 DNB|1053723431‏
996 ‎‡2 ISNI|000000007012742X‏
996 ‎‡2 NII|DA13507184‏
996 ‎‡2 PTBNP|1198122‏
996 ‎‡2 ISNI|0000000070728786‏
996 ‎‡2 BLBNB|001490721‏
996 ‎‡2 SUDOC|227310101‏
996 ‎‡2 ISNI|0000000068678812‏
996 ‎‡2 CAOONL|ncf10640975‏
996 ‎‡2 NUKAT|n 2011062369‏
996 ‎‡2 NYNYRILM|81256‏
996 ‎‡2 PTBNP|1052296‏
996 ‎‡2 ISNI|0000000068716348‏
996 ‎‡2 PTBNP|211768‏
996 ‎‡2 SUDOC|227787218‏
996 ‎‡2 PTBNP|88523‏
996 ‎‡2 BLBNB|000340927‏
996 ‎‡2 PTBNP|1524442‏
996 ‎‡2 BLBNB|000199551‏
996 ‎‡2 NTA|42260707X‏
996 ‎‡2 SUDOC|076994937‏
996 ‎‡2 ISNI|0000000068289032‏
996 ‎‡2 BNF|17165413‏
996 ‎‡2 ISNI|0000000068005992‏
996 ‎‡2 SUDOC|075898365‏
996 ‎‡2 BLBNB|000190598‏
996 ‎‡2 PTBNP|1042875‏
996 ‎‡2 PTBNP|287230‏
996 ‎‡2 LC|no2011016289‏
996 ‎‡2 ISNI|0000000084823477‏
996 ‎‡2 PTBNP|1156386‏
996 ‎‡2 LC|no2018089124‏
996 ‎‡2 DNB|1057299111‏
996 ‎‡2 PTBNP|84061‏
996 ‎‡2 LC|nb2014005322‏
996 ‎‡2 ISNI|0000000068516856‏
996 ‎‡2 BLBNB|000291464‏
996 ‎‡2 BLBNB|000441702‏
996 ‎‡2 PTBNP|1871318‏
996 ‎‡2 LC|n 82218748‏
996 ‎‡2 PTBNP|1362160‏
996 ‎‡2 PTBNP|962633‏
996 ‎‡2 BNF|13971554‏
996 ‎‡2 PTBNP|1318616‏
996 ‎‡2 LC|no2024063465‏
996 ‎‡2 ISNI|0000000067627503‏
996 ‎‡2 BNF|12221461‏
996 ‎‡2 PTBNP|905271‏
996 ‎‡2 LC|n 2017251765‏
996 ‎‡2 ISNI|0000000082099964‏
996 ‎‡2 ISNI|0000000070133280‏
996 ‎‡2 JPG|500704611‏
996 ‎‡2 ISNI|0000000068084440‏
996 ‎‡2 ISNI|0000000069525885‏
996 ‎‡2 RERO|A026506145‏
996 ‎‡2 BLBNB|000225266‏
996 ‎‡2 NTA|068950969‏
996 ‎‡2 PTBNP|1555725‏
996 ‎‡2 DNB|143600435‏
996 ‎‡2 PTBNP|997193‏
996 ‎‡2 ISNI|0000000066643309‏
996 ‎‡2 PTBNP|1426933‏
996 ‎‡2 LC|nr 97036479‏
996 ‎‡2 PTBNP|1259576‏
996 ‎‡2 PTBNP|98810‏
996 ‎‡2 SUDOC|08867570X‏
996 ‎‡2 ISNI|000000042841132X‏
996 ‎‡2 PTBNP|1441418‏
996 ‎‡2 PTBNP|179361‏
996 ‎‡2 ISNI|0000000052530063‏
996 ‎‡2 PTBNP|113592‏
996 ‎‡2 LC|no2022038975‏
996 ‎‡2 ISNI|0000000069313946‏
996 ‎‡2 BLBNB|000560608‏
996 ‎‡2 PTBNP|1019390‏
996 ‎‡2 DNB|1038872979‏
996 ‎‡2 ISNI|0000000070900697‏
996 ‎‡2 RERO|A012599319‏
996 ‎‡2 NII|DA1508546X‏
996 ‎‡2 LC|n 93015082‏
996 ‎‡2 DNB|1057375977‏
996 ‎‡2 ISNI|0000000115414482‏
996 ‎‡2 ISNI|000000035873654X‏
996 ‎‡2 DNB|1259381153‏
996 ‎‡2 BNF|13747966‏
996 ‎‡2 ISNI|0000000070624282‏
996 ‎‡2 PTBNP|1707639‏
996 ‎‡2 ISNI|000000008047867X‏
996 ‎‡2 CAOONL|ncf11227540‏
996 ‎‡2 ISNI|000000007325706X‏
996 ‎‡2 ISNI|0000000428386806‏
996 ‎‡2 LC|no2010046936‏
996 ‎‡2 BNF|15000313‏
996 ‎‡2 DNB|1074667425‏
996 ‎‡2 PLWABN|9810688829405606‏
996 ‎‡2 ISNI|0000000027594444‏
996 ‎‡2 ISNI|0000000371437296‏
996 ‎‡2 PTBNP|1791684‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏